UConn advances Prader-Willi research
A group of researchers from the UConn School of Medicine have received a nearly $3 million grant from the National Institutes of Health to investigate...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
A group of researchers from the UConn School of Medicine have received a nearly $3 million grant from the National Institutes of Health to investigate...
Connecticut Innovations sat down with Per Hellsund, president and CEO of Cybrexa Therapeutics, a bioscience startup whose technology targets cancer tumors. Here’s what he had...
Hyperfine Research has announced a partnership with Penn Medicine. The five-year-old startup, founded by genetics pioneer and New Haven native Jonathan Rothberg and housed in his 4Catalyzer...
BioXcel Therapeutics has reached a general agreement with the FDA on the key elements of the designs for its SERENITY (Sub-Lingual DExmedetomidine in Agitation Associated With SchizophRENIa...
Point72 Ventures reports that it is leading a $17 million fundraising round for a startup that produces software to speed up clinical trials. The startup...
Lewis Bender, CEO of a Connecticut startup called Intensity Therapeutics, feels compelled to cure cancer. “I had friends dying of cancer when I was in...
Over the course of 40 days on the International Space Station (ISS), researchers will determine the effect of microgravity on JAX’s Mighty Mice — genetically...
Human somatic cell genome editing is a promising treatment option for cardiovascular disorders, but concerns remain about the safety and efficacy of this therapeutic strategy....
Genesis Drug Discovery & Development, a member of Genesis Biotechnology Group, has acquired New England Discovery Partners (NEDP), a Contract Research Organization specializing in synthetic...
Achillion Pharmaceuticals reports that the FDA has reviewed and cleared the Investigational New Drug Application for ACH-5228, the company’s second-generation oral factor D inhibitor. The...